{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:56:19Z","timestamp":1791276979297,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute for Health Research Cambridge Biomedical Research Centre"},{"name":"Merck, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, and VBL Therapeutics"},{"name":"F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Merck, VBL Therapeutics, Novartis, Bristol-Myers Squibb, and Via Pharmaceuticals"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jcmg.2013.03.009","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T19:30:17Z","timestamp":1381779017000},"page":"1087-1094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Relationship of Serum Inflammatory Biomarkers With Plaque Inflammation Assessed by FDG PET\/CT"],"prefix":"10.1016","volume":"6","author":[{"given":"Rapha\u00ebl","family":"Duivenvoorden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kallend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Suchankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.F.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Tawakol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2013.03.009_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jcmg.2013.03.009_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology","volume":"89","author":"van der Wal","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2013.03.009_bib3","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jacc.2005.01.054","article-title":"Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction","volume":"45","author":"Mauriello","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2013.03.009_bib5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jcmg.2013.03.009_bib6","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"286","author":"Zhang","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jcmg.2013.03.009_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","article-title":"Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study","volume":"50","author":"Meuwese","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib8","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jcmg.2013.03.009_bib9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease","volume":"343","author":"Packard","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2013.03.009_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","article-title":"Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men","volume":"351","author":"Ridker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcmg.2013.03.009_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(01)06104-9","article-title":"Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis","volume":"358","author":"Malik","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jcmg.2013.03.009_bib12","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2013.03.009_bib13","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/S0735-1097(03)00482-0","article-title":"Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction","volume":"41","author":"Beyzade","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/ATVBAHA.108.165563","article-title":"Inflammation imaging in atherosclerosis","volume":"29","author":"Rudd","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2385-6-3","article-title":"Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation","volume":"6","author":"Zhang","year":"2006","journal-title":"BMC Nucl Med"},{"key":"10.1016\/j.jcmg.2013.03.009_bib16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In\u00a0vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCIMAGING.108.811752","article-title":"Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography\/computed tomography imaging study","volume":"2","author":"Rudd","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2013.03.009_bib18","first-page":"227","article-title":"Characterization of plaques using 18F-FDG PET\/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1","volume":"48","author":"Wu","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2013.03.009_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2967\/jnumed.110.080838","article-title":"Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: analysis with 18F-FDG PET","volume":"52","author":"Yoo","year":"2011","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2013.03.009_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2011.06.054","article-title":"High-sensitivity C-reactive protein in\u00a0the low- and intermediate-Framingham risk score groups: Analysis with 18F-fluorodeoxyglucose positron emission tomography","volume":"163","author":"Yang","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00259-011-1994-7","article-title":"The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers","volume":"39","author":"Wu","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2013.03.009_bib22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(11)61383-4","article-title":"Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial","volume":"378","author":"Fayad","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcmg.2013.03.009_bib23","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacc.2006.11.046","article-title":"Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome","volume":"49","author":"Tahara","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib24","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jcmg.2011.07.008","article-title":"Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study","volume":"4","author":"Bucerius","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2013.03.009_bib25","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jacc.2011.11.069","article-title":"Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake","volume":"59","author":"Bucerius","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI117342","article-title":"Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions","volume":"94","author":"Daugherty","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmg.2013.03.009_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1172\/JCI5549","article-title":"Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in\u00a0vitro","volume":"103","author":"Podrez","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmg.2013.03.009_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmg.2013.03.009_bib29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.0000140262.20831.8F","article-title":"Serum myeloperoxidase levels independently predict endothelial dysfunction in humans","volume":"110","author":"Vita","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2013.03.009_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.ATV.0000131784.50633.4f","article-title":"Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis","volume":"24","author":"Sugiyama","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmg.2013.03.009_bib31","unstructured":"The HRP Initiative. Available at: http:\/\/www.hrpinitiative.com. Accessed March 1,\u00a02013."}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X13005779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X13005779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:40:28Z","timestamp":1761846028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X13005779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1936878X13005779"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2013.03.009","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of Serum Inflammatory Biomarkers With Plaque Inflammation Assessed by FDG PET\/CT","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2013.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}